[HTML][HTML] A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
G Raghu, KK Brown, WZ Bradford… - … England Journal of …, 2004 - Mass Medical Soc
Background Idiopathic pulmonary fibrosis is a progressive, fatal disease with no known
efficacious therapy. Methods In a double-blind, multinational trial, we randomly assigned …
efficacious therapy. Methods In a double-blind, multinational trial, we randomly assigned …
[引用][C] A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
G RAGHU, KK BROWN… - The New England …, 2004 - pascal-francis.inist.fr
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary
fibrosis CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
fibrosis CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
[引用][C] A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
G RAGHU - N. Engl. J. Med., 2004 - cir.nii.ac.jp
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.
G Raghu, KK Brown, WZ Bradford, K Starko… - The New England …, 2004 - europepmc.org
BACKGROUND: Idiopathic pulmonary fibrosis is a progressive, fatal disease with no known
efficacious therapy. METHODS: In a double-blind, multinational trial, we randomly assigned …
efficacious therapy. METHODS: In a double-blind, multinational trial, we randomly assigned …
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
G Raghu, KK Brown, WZ Bradford… - The New England …, 2004 - pubmed.ncbi.nlm.nih.gov
Background Idiopathic pulmonary fibrosis is a progressive, fatal disease with no known
efficacious therapy. Methods In a double-blind, multinational trial, we randomly assigned …
efficacious therapy. Methods In a double-blind, multinational trial, we randomly assigned …
A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis
G Raghu, KK Brown, WZ Bradford, K Starko - New England Journal of …, 2004 - elibrary.ru
The median duration of treatment was 383 days in the interferon gamma-1b group (range,
13 to 643) and 374 days in the placebo group (range, 12 to 646). An average of 93 percent …
13 to 643) and 374 days in the placebo group (range, 12 to 646). An average of 93 percent …
[引用][C] A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
G RAGHU - N Engl J Med, 2004 - cir.nii.ac.jp